期刊文献+

促血管生成素-2与妊娠期高血压疾病的相关性 被引量:2

Correlation between angiopoietin-2 and hypertensive disorder complicating pregnancy
下载PDF
导出
摘要 目的检测妊娠期高血压疾病患者及其胎儿脐血血清中促血管生成素-2(Ang-2)的水平,以探讨Ang-2在妊娠期高血压疾病发病中的作用。方法采用酶联免疫吸附技术(ELISA)测定150例妊娠期高血压疾病患者,50例正常妊娠妇女及其胎儿脐血血清中Ang-2水平,并对数据进行分析。结果妊娠期高血压疾病患者中,血清Ang-2水平在妊娠期高血压组为(19.57±1.51)μg/L,轻度子痫前期组为(14.93±2.87)μg/L,重度子痫前期组为(10.85±1.45)μg/L,均明显低于对照组(22.79±2.93)μg/L,经比较有极显著性差异(t值分别为2.013、2.246、2.861,均P<0.05)。妊娠期高血压疾病新生儿中,脐血血清Ang-2水平在妊娠期高血压组为(21.43±1.21)μg/L,轻度子痫前期组为(17.55±1.67)μg/L,重度子痫前期组为(13.84±1.29)μg/L,均显著低于对照组(25.76±2.83)μg/L,经比较有极显著性差异(t值分别为2.253、2.391、2.682,均P<0.05)。结论孕妇血清中Ang-2水平与妊娠期高血压疾病的发病及病情轻重有关,而脐血血清中Ang-2与孕妇血清Ang-2水平一致。 Objective To detect the levels of angiopoietin -2 ( Ang-2 ) in serum of patients with hypertensive disorder complicating pregnancy ( HDCP) and umbilical cord blood of their fetuses, so as to explore the role of Ang-2 in pathogenesis of the disease.Methods Enzyme linked immunosorbent assay ( ELISA) was used to measure serum Ang-2 levels in 150 patients with HDCP and 50 normal pregnant women and those in their fetal umbilical cord.Results Ang-2 level in HDCP group ( gestational hypertension group:19.57 ±1.51μg/L;mild preeclampsia group:14.93 ±2.87μg/L;severe preeclampsia group:10.85 ±1.45μg/L) was significantly lower than that (22.79 ± 2.93μg/L) in normal pregnant group (t value was 2.013, 2.246 and 2.861, respectively, all P〈0.05).There was also difference in serum level of Ang-2 in umbilical cord between HDCP group ( gestational hypertension group: 21.43 ±1.21μg/L;mild preeclampsia group:17.55 ±1.67μg/L;severe preeclampsia group:13.84 ±1.29μg/L) and the control group (25.76 ±2.83μg/L), and the difference was significant ( t value was 2.253, 2.391 and 2.682, respectively, all P〈0.05) .Conclusion The levels of Ang-2 in pregnant women are correlated with the pathogenesis and severity of HDCP, and they are in accordance with those in umbilical cord.
出处 《中国妇幼健康研究》 2015年第4期692-694,共3页 Chinese Journal of Woman and Child Health Research
关键词 妊娠期高血压疾病 促血管生成素-2 胎儿 脐血 hypertensive disorder complicating pregnancy (HDCP) angiopoietin-2 ( Ang-2 ) fetus umbilical cord blood
  • 相关文献

参考文献10

  • 1方明,何元芬,章庆华.妊娠期高血压疾病发病的高危因素研究[J].中国医药导刊,2014,16(2):229-230. 被引量:11
  • 2Cui K, Yan T, Luo Q, et al. Ultrasound microbubble-mediated delivery of integrin-linked kinase gene improves endothelial progenitor cells dysfunction in pre-eclampsia[ J. DNA Cell Biol, 2014,33 (5) : 301-310.
  • 3谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 4Abdullah B, Deveci K, Atilgan R, et al. Serum angiopoietin-related growth factor(AGF) levels are elevated in gestational diabetes mellitus and associated with insulin resistance[ J]. Ginekol Pol,2012,83 (10) : 749-753.
  • 5Jiart W, Levitt J M, Lerner S P. The angiopoietin-TIE2 pathway is a potential therapeutic target in urothelial carcinoma [ J ]. Anticancer Res,2014,34 ( 7 ) :3377-3382.
  • 6Staton C A, Vallum M, Hoh L, et al. Angiopoietin-1, angiopoietin-2 and Tie-2 receptor expression in human dermal wound repair and scarring [ J ]. Br J Dermato1,2010,163 ( 5 ) :920-927.
  • 7Borowicz P P, Arnold D R, Johnson M L. Placental growth throughout the last two thirds of pregnancy in sheep: Vascular development and angiogenic factor expression [ J 1. Biol Reprod,2007, 76(2) :259-267.
  • 8Leinonen E, Wath6n KA, Alfthan H, et al. Maternal serum angiopoietin-1 and -2 and tie-2 in early pregnancy ending in preeclampsia or intrauterine growth retardation I J I. Clin Endocrinol Metab,2010,95 ( 1 ) : 126-133.
  • 9Kim H A, Seo K H, Kang Y R, et al. Mechanisms of platelet- activating factor-induced enhancement of VEGF expression [ J 1. Cell Physiol Biochem ,2011,27 ( 1 ) :55-62.
  • 10Woolnough C, Wang Y, Kan C Y, et al. Source of angiopoietin-2 in the sera of women during pregnancy [ J ]. Microvasc Res, 2012,84 (3) :367-374.

二级参考文献11

共引文献1262

同被引文献21

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部